Cargando…

Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis

BACKGROUND: Cerebral microdialysis (MD) provides valuable information about brain metabolism under normal and pathologic conditions. The CMA 600 microdialysis analyzer received US Food and Drug Administration (FDA) approval for clinical use in the United States in 2005. Since then, cerebral MD has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jeff W., Rogers, Shana L., Gombart, Zoe J., Adler, David E., Cecil, Sandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385066/
https://www.ncbi.nlm.nih.gov/pubmed/22754722
http://dx.doi.org/10.4103/2152-7806.96868
_version_ 1782236790702211072
author Chen, Jeff W.
Rogers, Shana L.
Gombart, Zoe J.
Adler, David E.
Cecil, Sandy
author_facet Chen, Jeff W.
Rogers, Shana L.
Gombart, Zoe J.
Adler, David E.
Cecil, Sandy
author_sort Chen, Jeff W.
collection PubMed
description BACKGROUND: Cerebral microdialysis (MD) provides valuable information about brain metabolism under normal and pathologic conditions. The CMA 600 microdialysis analyzer received US Food and Drug Administration (FDA) approval for clinical use in the United States in 2005. Since then, cerebral MD has been increasingly utilized nationally in the multimodal monitoring of traumatic brain injury (TBI), stroke, aneurysmal subarachnoid hemorrhage, and brain tumors. We describe a 5-year, single-institutional experience using cerebral MD at a community-based hospital, Legacy Emanuel Medical Center (LEMC). Implications for the adoption and utility of MD in medical centers with limited resources are discussed. METHODS: This is a retrospective chart review and data analysis of 174 consecutive patients who had cerebral MD as part of multimodal brain monitoring. All cerebral MD catheters were placed by board-certified, attending neurosurgeons at LEMC. Clinical severity in the TBI patients was reported using initial Glasgow Coma Scale (GCS); radiologic severity was graded with the Marshall CT grading scale. Measures of the risks of MD placement included post-placement hemorrhage, cerebral infection, and dislodgement. RESULTS: Between July 2005 and July 2010, 248 cerebral MD catheters were placed in 174 patients undergoing multimodal brain monitoring. One hundred and eighty-five catheters were placed at the time of open craniotomy. None were associated with cranial infection. Patients ranged in age from 5 months to 90 years, with a mean of 49 years. The male to female ratio was 1.4:1. The underlying pathologies were: TBI (126), cerebral vascular accident (24), aneurysmal subarachnoid hemorrhage (17), and tumor (7). CONCLUSIONS: Cerebral MD was readily implemented in a community-based hospital. No cerebral hemorrhages or infections were attributed to cerebral MD. Examples of how MD may be a useful adjunct in the clinical decision making of patients with brain injuries are presented.
format Online
Article
Text
id pubmed-3385066
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33850662012-07-02 Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis Chen, Jeff W. Rogers, Shana L. Gombart, Zoe J. Adler, David E. Cecil, Sandy Surg Neurol Int Original Article BACKGROUND: Cerebral microdialysis (MD) provides valuable information about brain metabolism under normal and pathologic conditions. The CMA 600 microdialysis analyzer received US Food and Drug Administration (FDA) approval for clinical use in the United States in 2005. Since then, cerebral MD has been increasingly utilized nationally in the multimodal monitoring of traumatic brain injury (TBI), stroke, aneurysmal subarachnoid hemorrhage, and brain tumors. We describe a 5-year, single-institutional experience using cerebral MD at a community-based hospital, Legacy Emanuel Medical Center (LEMC). Implications for the adoption and utility of MD in medical centers with limited resources are discussed. METHODS: This is a retrospective chart review and data analysis of 174 consecutive patients who had cerebral MD as part of multimodal brain monitoring. All cerebral MD catheters were placed by board-certified, attending neurosurgeons at LEMC. Clinical severity in the TBI patients was reported using initial Glasgow Coma Scale (GCS); radiologic severity was graded with the Marshall CT grading scale. Measures of the risks of MD placement included post-placement hemorrhage, cerebral infection, and dislodgement. RESULTS: Between July 2005 and July 2010, 248 cerebral MD catheters were placed in 174 patients undergoing multimodal brain monitoring. One hundred and eighty-five catheters were placed at the time of open craniotomy. None were associated with cranial infection. Patients ranged in age from 5 months to 90 years, with a mean of 49 years. The male to female ratio was 1.4:1. The underlying pathologies were: TBI (126), cerebral vascular accident (24), aneurysmal subarachnoid hemorrhage (17), and tumor (7). CONCLUSIONS: Cerebral MD was readily implemented in a community-based hospital. No cerebral hemorrhages or infections were attributed to cerebral MD. Examples of how MD may be a useful adjunct in the clinical decision making of patients with brain injuries are presented. Medknow Publications & Media Pvt Ltd 2012-05-31 /pmc/articles/PMC3385066/ /pubmed/22754722 http://dx.doi.org/10.4103/2152-7806.96868 Text en Copyright: © 2012 Chen JW. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Original Article
Chen, Jeff W.
Rogers, Shana L.
Gombart, Zoe J.
Adler, David E.
Cecil, Sandy
Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis
title Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis
title_full Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis
title_fullStr Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis
title_full_unstemmed Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis
title_short Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis
title_sort implementation of cerebral microdialysis at a community-based hospital: a 5-year retrospective analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385066/
https://www.ncbi.nlm.nih.gov/pubmed/22754722
http://dx.doi.org/10.4103/2152-7806.96868
work_keys_str_mv AT chenjeffw implementationofcerebralmicrodialysisatacommunitybasedhospitala5yearretrospectiveanalysis
AT rogersshanal implementationofcerebralmicrodialysisatacommunitybasedhospitala5yearretrospectiveanalysis
AT gombartzoej implementationofcerebralmicrodialysisatacommunitybasedhospitala5yearretrospectiveanalysis
AT adlerdavide implementationofcerebralmicrodialysisatacommunitybasedhospitala5yearretrospectiveanalysis
AT cecilsandy implementationofcerebralmicrodialysisatacommunitybasedhospitala5yearretrospectiveanalysis